{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:13:26Z","timestamp":1792181606206,"version":"4.4.0"},"reference-count":190,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Mucormycosis (MCR) is an emerging and frequently lethal fungal infection caused by the Mucorales family, with <jats:italic>Rhizopus<\/jats:italic>, <jats:italic>Mucor<\/jats:italic>, and <jats:italic>Lichtheimia<\/jats:italic>, accounting for &amp;gt; 90% of all cases. MCR is seen in patients with severe immunosuppression such as those with hematologic malignancy or transplantation, Diabetes Mellitus (DM) and diabetic ketoacidosis (DKA) and immunocompetent patients with severe wounds. The recent SARS COV2 epidemy in India has resulted in a tremendous increase in MCR cases, typically seen in the setting of uncontrolled DM and corticosteroid use. In addition to the diversity of affected hosts, MCR has pleiotropic clinical presentations, with rhino-orbital\/rhino-cerebral, sino-pulmonary and necrotizing cutaneous forms being the predominant manifestations. Major insights in MCR pathogenesis have brought into focus the host receptors (GRP78) and signaling pathways (EGFR activation cascade) as well as the adhesins used by Mucorales for invasion. Furthermore, studies have expanded on the importance of iron availability and the complex regulation of iron homeostasis, as well as the pivotal role of mycotoxins as key factors for tissue invasion. The molecular toolbox to study Mucorales pathogenesis remains underdeveloped, but promise is brought by RNAi and CRISPR\/Cas9 approaches. Important recent advancements have been made in early, culture-independent molecular diagnosis of MCR. However, development of new potent antifungals against Mucorales remains an unmet need. Therapy of MCR is multidisciplinary and requires a high index of suspicion for initiation of early Mucorales-active antifungals. Reversal of underlying immunosuppression, if feasible, rapid DKA correction and in selected patients, surgical debulking are crucial for improved outcomes.<\/jats:p>","DOI":"10.3389\/fcimb.2023.1254919","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T20:11:26Z","timestamp":1695327086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":135,"title":["Mucormycosis in 2023: an update on pathogenesis and management"],"prefix":"10.3389","volume":"13","author":[{"given":"Abdullah","family":"Alqarihi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/cei.12170","article-title":"Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing","volume":"174","author":"Aberdein","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/01.inf.0000134314.65398.bf","article-title":"Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children","volume":"23","author":"Abzug","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/mmy\/myw080","article-title":"Performance evaluation of multiplex PCR including Aspergillus-not so simple","volume":"55","author":"Alanio","year":"2017","journal-title":"Med. Mycol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole antifungals: 35 years of invasive fungal infection management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e01087","DOI":"10.1128\/mBio.01087-20","article-title":"GRP78 and integrins play different roles in host cell invasion during mucormycosis","volume":"11","author":"Alqarihi","year":"2020","journal-title":"mBio"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/j.ijid.2009.11.024","article-title":"Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors","volume":"14","author":"Ambrosioni","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1038\/s41467-018-05820-2","article-title":"Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species","volume":"9","author":"Andrianaki","year":"2018","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00438-004-1008-6","article-title":"A multicopy vector system for genetic studies in Mucor circinelloides and other zygomycetes","volume":"271","author":"Appel","year":"2004","journal-title":"Mol. Genet. Genomics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"B11","unstructured":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00746","DOI":"10.1128\/JCM.00746-18","article-title":"PCR-based approach targeting Mucorales specific gene family for the diagnosis of mucormycosis","volume":"56","author":"Baldin","year":"2018","journal-title":"J. Clin. Microbiol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/ofid\/ofx163.136","article-title":"editors. Optimization of the CRISPR\/Cas9 system to manipulate gene function in Rhizopus delemar","volume":"4","author":"Baldin","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1128\/AAC.45.12.3601-3602.2001","article-title":"Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model","volume":"45","author":"Barratt","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","article-title":"A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response","volume":"59","author":"Ben-Ami","year":"2009","journal-title":"J. Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2012.03976.x","article-title":"Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species","volume":"19","author":"Bernal-Martinez","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-4453(94)95896-3","article-title":"Mucormycosis (zygomycosis): is there news for the clinician","author":"Boelaert","year":"1994","journal-title":"J. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI116419","article-title":"Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies","volume":"91","author":"Boelaert","year":"1993","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/infdis\/160.5.914","article-title":"Registry on mucormycosis in dialysis patients [letter]","volume":"160","author":"Boelaert","year":"1989","journal-title":"J. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0272-6386(12)80606-8","article-title":"Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry","volume":"18","author":"Boelaert","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ki.1994.89","article-title":"Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect","volume":"45","author":"Boelaert","year":"1994","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7326\/0003-4819-107-5-782_2","article-title":"Mucormycosis infection in dialysis patients [letter]","volume":"107","author":"Boelaert","year":"1987","journal-title":"Ann. Internal Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/jof7040271","article-title":"In vitro antifungal drug resistance profiles of clinically relevant members of the mucorales (Mucoromycota) especially with the newer triazoles","volume":"7","author":"Borman","year":"2021","journal-title":"J. Fungi (Basel)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fgb.2018.12.002","article-title":"CRISPR-Cas9 induces point mutation in the mucormycosis fungus Rhizopus delemar","volume":"124","author":"Bruni","year":"2019","journal-title":"Fungal Genet. Biol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"ofw190","DOI":"10.1093\/ofid\/ofw190","article-title":"Is it time to include CT \u201cReverse halo sign\u201d and qPCR targeting mucorales in serum to EORTC-MSG criteria for the diagnosis of pulmonary mucormycosis in leukemia patients","volume":"3","author":"Caillot","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nature13575","article-title":"Antifungal drug resistance evoked via RNAi-dependent epimutations","volume":"513","author":"Calo","year":"2014","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0022-2143(99)90066-5","article-title":"Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis","volume":"133","author":"Cantinieaux","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100759","article-title":"The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection","volume":"296","author":"Carlos","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.biocel.2017.06.005","article-title":"The rhizoferrin biosynthetic gene in the fungal pathogen Rhizopus delemar is a novel member of the NIS gene family","volume":"89","author":"Carroll","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.omtm.2018.03.003","article-title":"A new method for reactivating and expanding T cells specific for Rhizopus oryzae","volume":"9","author":"Castillo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcrc.2019.02.005","article-title":"Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)","volume":"51","author":"Chakrabarti","year":"2019","journal-title":"J. Crit. Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: unique features","author":"Chakrabarti","year":"2014","journal-title":"Mycoses"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e12955","DOI":"10.1371\/journal.pone.0012955","article-title":"Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses","volume":"5","author":"Chamilos","year":"2010","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic Malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12218","DOI":"10.1038\/ncomms12218","article-title":"An integrated genomic and transcriptomic survey of mucormycosis-causing fungi","volume":"7","author":"Chibucos","year":"2016","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1128\/iai.38.3.1123-1129.1982","article-title":"Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis","volume":"38","author":"Chinn","year":"1982","journal-title":"Infect. Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/QCO.0000000000000277","article-title":"Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents","volume":"29","author":"Chitasombat","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/jof8040352","article-title":"Targeted delivery of antifungal liposomes to Rhizopus delemar","volume":"8","author":"Choudhury","year":"2022","journal-title":"J. Fungi (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737159.2018.1522250","article-title":"Recent advances in the molecular diagnosis of mucormycosis","volume":"18","author":"Dadwal","year":"2018","journal-title":"Expert Rev. Mol. Diagnost."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/jac\/dkv198","article-title":"Invasive mould sinusitis in patients with haematological Malignancies: a 10 year single-centre study","volume":"70","author":"Davoudi","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/0006-2952(94)90314-X","article-title":"Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus","volume":"47","author":"de Locht","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/iai.38.2.487-495.1982","article-title":"Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro","volume":"38","author":"Diamond","year":"1982","journal-title":"Infect. Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1128\/iai.38.1.380-382.1982","article-title":"Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans","volume":"38","author":"Diamond","year":"1982","journal-title":"Infect. Immun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mycmed.2018.02.014","article-title":"Mucormycosis in Iran: A six-year retrospective experience","volume":"28","author":"Dolatabadi","year":"2018","journal-title":"J. Mycol. M\u00e9dicale"},{"key":"B47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B48","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1586\/eri.09.67","article-title":"New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance","volume":"7","author":"Fera","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/clinids\/10.3.551","article-title":"Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis","volume":"10","author":"Ferguson","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00707","article-title":"Fungal biodiversity and their role in soil health","volume":"9","author":"Fr\u0105c","year":"2018","journal-title":"Front. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.femsle.2004.04.031","article-title":"Cloning and functional characterization of the Rhizopus oryzae high affinity iron permease (rFTR1) gene","volume":"235","author":"Fu","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"B52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40588-018-0097-7","article-title":"Genetic tools for investigating Mucorales fungal pathogenesis","volume":"5","author":"Garcia","year":"2018","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/jof8050445","article-title":"Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis","volume":"8","author":"Garc\u00eda-Carnero","year":"2022","journal-title":"J. Fungi"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e00178","DOI":"10.1128\/AAC.00178-20","article-title":"Fosmanogepix (APX001) is effective in the treatment of pulmonary murine mucormycosis due to Rhizopus arrhizus","volume":"64","author":"Gebremariam","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"eaaw1327","DOI":"10.1126\/sciadv.aaw1327","article-title":"Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis","volume":"5","author":"Gebremariam","year":"2019","journal-title":"Sci. Adv."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0038022","DOI":"10.1128\/aac.00380-22","article-title":"The combination treatment of fosmanogepix and liposomal amphotericin B is superior to monotherapy in treating experimental invasive mold infections","volume":"66","author":"Gebremariam","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/jac\/dkab233","article-title":"Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis","volume":"76","author":"Gebremariam","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1172\/JCI82744","article-title":"Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis","volume":"126","author":"Gebremariam","year":"2016","journal-title":"J. Clin. Invest"},{"key":"B59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1128\/AAC.01437-15","article-title":"VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection","volume":"59","author":"Gebremariam","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/428503","article-title":"Interferon- gamma and Granulocyte-Macrophage Colony-Stimulating Factor Augment the Activity of Polymorphonuclear Leukocytes against Medically Important Zygomycetes","volume":"191","author":"Gil-Lamaignere","year":"2005","journal-title":"J. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3; in the treatment of intractable mucormycosis","volume":"17","author":"Grimaldi","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B65","volume-title":"A humanized antibody targeting the CotH invasins is protective against murine mucormycosis. Open Forum Infect Dis","author":"Gu","year":"2021"},{"key":"B66","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5414\/CNP58134","article-title":"Impact of iron dextran on polymorphonuclear cell function among hemodialysis patients","volume":"58","author":"Guo","year":"2002","journal-title":"Clin. Nephrol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.708550","article-title":"Long-reads-based metagenomics in clinical diagnosis with a special focus on fungal infections","volume":"12","author":"Hoang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1128\/CMR.12.3.394","article-title":"Acquisition, transport, and storage of iron by pathogenic fungi","volume":"12","author":"Howard","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis","volume":"77","author":"Ibrahim","year":"2010","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/myc.12232","article-title":"Host-iron assimilation: pathogenesis and novel therapies of mucormycosis","author":"Ibrahim","year":"2014","journal-title":"Mycoses"},{"key":"B72","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4419-6640-7_15","article-title":"Mucormycosis and entomophtoramycosis (Zygomycosis)","volume-title":"Essentials of Clinical Mycology","author":"Ibrahim","year":"2011"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.3390\/ijms21103727","article-title":"CRISPR-Cas9-base mutagenesis of the mucormycosis-causing fungus Lichtheimia corymbifera","volume":"22","author":"Ibragimova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis","volume":"77","author":"Ibrahim","year":"2010","journal-title":"Mol. Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1128\/AAC.01124-08","article-title":"Posaconazole mono- or combination therapy for treatment of murine zygomycosis","volume":"53","author":"Ibrahim","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/IAI.73.2.778-783.2005","article-title":"Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro","volume":"73","author":"Ibrahim","year":"2005","journal-title":"Infect. Immun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","author":"Ibrahim","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mib.2017.10.010","article-title":"The mucormycete\u2013host interface","volume":"40","author":"Ibrahim","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jof5020027","article-title":"Animal models to study mucormycosis","volume":"5","author":"Jacobsen","year":"2019","journal-title":"J. Fungi (Basel Switzerland)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"John","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"B85","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John","year":"2021","journal-title":"J. Fungi (Basel)."},{"key":"B86","doi-asserted-by":"publisher","first-page":"684 e11","DOI":"10.1016\/j.cmi.2015.03.019","article-title":"Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis","volume":"21","author":"Jung","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B87","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01376517-199506000-00006","article-title":"Hyperbaric oxygen therapy for rhinocerebral fungal infection","volume":"27","author":"Kajs-Wyllie","year":"1995","journal-title":"J. Neurosci. Nurs."},{"key":"B88","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1309\/7KU5XWURYM0151YN","article-title":"Increased culture recovery of Zygomycetes under physiologic temperature conditions","volume":"127","author":"Kontoyiannis","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/cid\/cir886","article-title":"Future directions in mucormycosis research","author":"Konotoyiannis","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"E139","DOI":"10.1152\/ajpendo.00480.2020","article-title":"COVID-19 endocrinopathy with hindsight from SARS","volume":"320","author":"Kothandaraman","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic Malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin. Microbiol. Infect"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e01244","DOI":"10.1128\/AAC.01244-19","article-title":"Therapeutic challenges of non-aspergillus invasive mold infections in immunosuppressed patients","volume":"63","author":"Lamoth","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B95","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jof7010017","article-title":"Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections","volume":"7","author":"Lamoth","year":"2020","journal-title":"J. Fungi (Basel)."},{"key":"B96","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: A clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin. Infect. Dis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00294-003-0484-2","article-title":"Characterisation of the Mucor circinelloides regulated promoter gpd1P","volume":"45","author":"Larsen","year":"2004","journal-title":"Curr. Genet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1469-0691.2009.02999.x","article-title":"Zygomycosis: conventional laboratory diagnosis","author":"Lass-Fl\u00f6rl","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"B100","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.crmeth.2021.100124","article-title":"Stable and reproducible homologous recombination enables CRISPR-based engineering in the fungus Rhizopus microsporus","volume":"1","author":"Lax","year":"2021","journal-title":"Cell Rep. Methods"},{"key":"B101","doi-asserted-by":"publisher","first-page":"101237","DOI":"10.1016\/j.xpro.2022.101237","article-title":"Transformation and CRISPR-Cas9-mediated homologous recombination in the fungus Rhizopus microsporus","volume":"3","author":"Lax","year":"2022","journal-title":"STAR Protoc."},{"key":"B102","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/genes11030317","article-title":"Genes, pathways, and mechanisms involved in the virulence of mucorales","volume":"11","author":"Lax","year":"2020","journal-title":"Genes (Basel)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-07-0325","article-title":"GRP78 induction in cancer: therapeutic and prognostic implications","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e01390","DOI":"10.1128\/mBio.01390-14","article-title":"Analysis of a food-borne fungal pathogen outbreak: virulence and genome of a Mucor circinelloides isolate from yogurt","volume":"5","author":"Lee","year":"2014","journal-title":"mBio"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e1003625","DOI":"10.1371\/journal.ppat.1003625","article-title":"Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides","volume":"9","author":"Lee","year":"2013","journal-title":"PloS Pathogens"},{"key":"B106","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/mmi.13071","article-title":"Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides","volume":"97","author":"Lee","year":"2015","journal-title":"Mol. Microbiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: the last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch. Internal Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1128\/MMBR.00005-10","article-title":"The evolution of sex: a perspective from the fungal kingdom","volume":"74","author":"Lee","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.805964","article-title":"Potential advances of adjunctive hyperbaric oxygen therapy in infective endocarditis","volume":"12","author":"Lerche","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"e1002086","DOI":"10.1371\/journal.ppat.1002086","article-title":"Sporangiospore size dimorphism is linked to virulence of Mucor circinelloides","volume":"7","author":"Li","year":"2011","journal-title":"PloS Pathog."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e1004842","DOI":"10.1145\/2818302","article-title":"Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine","volume":"11","author":"Liu","year":"2015","journal-title":"PloS Pathog."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B114","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1093\/cid\/ciaa1836","article-title":"Molecular techniques for genus and species determination of fungi from fresh and paraffin-embedded formalin-fixed tissue in the revised EORTC\/MSGERC definitions of invasive fungal infection","volume":"72","author":"Lockhart","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e1000549","DOI":"10.1371\/journal.pgen.1000549","article-title":"Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication","volume":"5","author":"Ma","year":"2009","journal-title":"PloS Genet."},{"key":"B116","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/mmy\/myy042","article-title":"Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment","volume":"57","author":"Maurer","year":"2019","journal-title":"Med. Mycol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S474","DOI":"10.1093\/infdis\/jix130","article-title":"Novel agents and drug targets to meet the challenges of resistant fungi","volume":"216","author":"McCarthy","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/14737159.2016.1219253","article-title":"PCR methodology and applications for the detection of human fungal pathogens","volume":"16","author":"McCarthy","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B121","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin. Infect. Dis"},{"key":"B122","doi-asserted-by":"publisher","first-page":"810.e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1093\/cid\/cit094","article-title":"Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients","volume":"56","author":"Millon","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.fbr.2016.11.002","article-title":"Mucor: a janus-faced fungal genus with human health impact and industrial applications","volume":"31","author":"Morin-Sardin","year":"2017","journal-title":"Fungal Biol. Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jdermsci.2005.01.010","article-title":"Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene","volume":"39","author":"Nagao","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"16800","DOI":"10.1038\/s41598-017-17118-2","article-title":"Development of a plasmid free CRISPR-Cas9 system for the genetic modification of Mucor circinelloides","volume":"7","author":"Nagy","year":"2017","journal-title":"Sci. Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1038\/s41598-018-26051-x","article-title":"Components of a new gene family of ferroxidases involved in virulence are functionally specialized in fungal dimorphism","volume":"8","author":"Navarro-Mendoza","year":"2018","journal-title":"Sci. Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"E3482","DOI":"10.1073\/pnas.1605917113","article-title":"Phosphorylation of spore coat proteins by a family of atypical protein kinases","volume":"113","author":"Nguyen","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00253-007-1281-5","article-title":"Lycopene over-accumulation by disruption of the negative regulator gene crgA in Mucor circinelloides","volume":"78","author":"Nicolas-Molina","year":"2008","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/myc.12958","article-title":"Mucormycosis in South America: A review of 143 reported cases","volume":"62","author":"Nucci","year":"2019","journal-title":"Mycoses"},{"key":"B131","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1079\/BJN19940094","article-title":"The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse","volume":"72","author":"Omara","year":"1994","journal-title":"Br. J. Nutr."},{"key":"B132","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1128\/mr.55.2.234-258.1991","article-title":"Mucor dimorphism","volume":"55","author":"Orlowski","year":"1991","journal-title":"Microbiol. Rev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease\u2013associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg. Infect. Dis. J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00294-017-0798-0","article-title":"Control of morphology and virulence by ADP-ribosylation factors (Arf) in Mucor circinelloides","volume":"64","author":"Pati\u00f1o-Medina","year":"2018","journal-title":"Curr. Genet."},{"key":"B135","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1469-0691.2009.02988.x","article-title":"Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices","author":"Pongas","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"B137","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1182\/blood-2011-07-366526","article-title":"Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients","volume":"118","author":"Potenza","year":"2011","journal-title":"Blood"},{"key":"B138","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"},{"key":"B139","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1288\/00005537-198005000-00002","article-title":"Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis","volume":"90","author":"Price","year":"1980","journal-title":"Laryngoscope"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave","volume":"9","author":"Raut","year":"2021","journal-title":"Lancet Respir. Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: Mucormycosis in COVID-19 times","volume":"69","author":"Ravani","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"B144","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118781","article-title":"High GRP78 levels in Covid-19 infection: A case-control study","volume":"265","author":"Sabirli","year":"2021","journal-title":"Life Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1099\/mic.0.26108-0","article-title":"Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase","volume":"149","author":"Santos","year":"2003","journal-title":"Microbiology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.imbio.2012.10.013","article-title":"Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity","volume":"218","author":"Schmidt","year":"2013","journal-title":"Immunobiology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/gen.32.21.19","article-title":"Overcoming drawbacks of gene silencing with RNAi","volume":"32","author":"Schmitt","year":"2012","journal-title":"Genet. Eng. Biotechnol. News."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e1004496","DOI":"10.1371\/journal.pgen.1004496","article-title":"Gene expansion shapes genome architecture in the human pathogen Lichtheimia corymbifera: an evolutionary genomics analysis in the ancient terrestrial mucorales (Mucoromycotina)","volume":"10","author":"Schwartze","year":"2014","journal-title":"PloS Genet."},{"key":"B150","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: A review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J. Fungi (Basel)."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e108635","DOI":"10.1371\/journal.pone.0108635","article-title":"Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis","volume":"9","author":"Shirazi","year":"2014","journal-title":"PloS One"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00172-18","article-title":"In situ validation of the endothelial cell receptor GRP78 in a case of Rhinocerebral mucormycosis","volume":"62","author":"Shumilov","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B153","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"B154","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41564-020-00837-0","article-title":"Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis","volume":"6","author":"Soliman","year":"2021","journal-title":"Nat. Microbiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"PloS Pathog."},{"key":"B157","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B158","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B159","article-title":"Mucormycosis","volume-title":"Harrison\u2019s Principles of Internal Medicine, 19e","author":"Spellberg","year":"2015"},{"key":"B160","article-title":"Mucormycosis","volume-title":"Harrison\u2019s Principles of Internal Medicine, 20e","author":"Spellberg","year":"2018"},{"key":"B161","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B162","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how","author":"Spellberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3109\/13693786.2012.669502","article-title":"Risk factors for mortality in patients with mucormycosis","volume":"50","author":"Spellberg","year":"2012","journal-title":"Med. Mycol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1099\/jmm.0.000375","article-title":"Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples","volume":"65","author":"Springer","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12281-020-00370-x","article-title":"Extrapolating antifungal animal data to humans - Is it reliable","volume":"14","author":"Stevens","year":"2020","journal-title":"Curr. Fungal Infect. Rep."},{"key":"B166","first-page":"2973","article-title":"Agents of mucormycosis and related species","volume-title":"Principles and Practice of Infectious Diseases. 2","author":"Sugar","year":"2005"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e0338622","DOI":"10.1128\/mbio.03386-22","article-title":"cotH genes are necessary for normal spore formation and virulence in Mucor lusitanicus","volume":"14","author":"Szebenyi","year":"2023","journal-title":"mBio"},{"key":"B168","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/JCM.43.1.382-386.2005","article-title":"Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery","volume":"43","author":"Tarrand","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1574-6968.1992.tb05285.x","article-title":"Rhizoferrin: a complexone type siderophore of the Mucorales and entomophthorales (Zygomycetes)","volume":"73","author":"Thieken","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJMc1300111","article-title":"Trauma Infectious Diseases Outcomes Study Group of the Infectious Disease Clinical Research P. Mucormycosis after a tornado in Joplin, Missouri","volume":"368","author":"Tribble","year":"2013","journal-title":"N Engl. J. Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e1006150","DOI":"10.1371\/journal.ppat.1006150","article-title":"RNAi-based functional genomics identifies new virulence determinants in mucormycosis","volume":"13","author":"Trieu","year":"2017","journal-title":"PloS Pathogens"},{"key":"B172","doi-asserted-by":"publisher","first-page":"23639","DOI":"10.1074\/jbc.M301044200","article-title":"GWT1 gene is required for inositol acylation of glycosylphosphatidylinositol anchors in yeast","volume":"278","author":"Umemura","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B173","volume-title":"Encyclopedia of Mycology","author":"Uppuluri","year":"2021"},{"key":"B174","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"O336","DOI":"10.1111\/1469-0691.12408","article-title":"Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival","volume":"20","author":"Vironneau","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B176","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3767\/persoonia.2020.44.03","article-title":"A new species concept for the clinically relevant Mucor circinelloides complex","volume":"44","author":"Wagner","year":"2020","journal-title":"Persoonia"},{"key":"B177","first-page":"243","article-title":"Pulmonary defense mechanisms against opportunistic fungal pathogens","volume":"47","author":"Waldorf","year":"1989","journal-title":"Immunol. Series"},{"key":"B178","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/infdis\/150.5.752","article-title":"In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus","volume":"150","author":"Waldorf","year":"1984","journal-title":"J. Infect. Dis."},{"key":"B179","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus","volume":"74","author":"Waldorf","year":"1984","journal-title":"J. Clin. Invest."},{"key":"B180","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","author":"Walsh","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/cid\/cis749","article-title":"Invasive mold infections following combat-related injuries","volume":"55","author":"Warkentien","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B182","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1128\/JCM.00835-15","article-title":"Impact of mucorales and other invasive molds on clinical outcomes of polymicrobial traumatic wound infections","volume":"53","author":"Warkentien","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"e01384","DOI":"10.1128\/mBio.01384-18","article-title":"Inhibition of EGFR signaling protects from mucormycosis","volume":"9","author":"Watkins","year":"2018","journal-title":"mBio"},{"key":"B184","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1017\/S095026881400051X","article-title":"Combat trauma-associated invasive fungal wound infections: epidemiology and clinical classification","volume":"143","author":"Weintrob","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"B185","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1567-1364.2002.tb00085.x","article-title":"Identification and analysis of genes involved in the control of dimorphism in Mucor circinelloides (syn. racemosus)","volume":"2","author":"Wolff","year":"2002","journal-title":"FEMS Yeast Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/02681218880000211","article-title":"Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores","volume":"26","author":"Worsham","year":"1988","journal-title":"J. Med. Vet. Mycol."},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838344","article-title":"Blockade of the PD-1\/PD-L1 immune checkpoint pathway improves infection outcomes and enhances fungicidal host defense in a murine model of invasive pulmonary mucormycosis","volume":"13","author":"Wurster","year":"2022","journal-title":"Front. Immunol."},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108896","article-title":"EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion","volume":"34","author":"Wurster","year":"2021","journal-title":"Cell Rep."},{"key":"B189","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.diagmicrobio.2012.01.013","article-title":"Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures","volume":"73","author":"Yaman","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1099\/jmm.0.000560","article-title":"Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples","volume":"66","author":"Zaman","year":"2017","journal-title":"J. Med. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1254919\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T20:11:34Z","timestamp":1695327094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1254919\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":190,"alternative-id":["10.3389\/fcimb.2023.1254919"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1254919","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"article-number":"1254919"}}